Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantation.
Jonas
S
S
Department of Surgery, Humboldt University Berlin, Germany.
Guckelberger
O
O
Bechstein
W O
WO
Berg
T
T
Müller
A R
AR
Platz
K P
KP
Tullius
S G
SG
Settmacher
U
U
Steinmüller
T
T
Hopf
U
U
Neuhaus
P
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000453:epidemiology; D011183:Postoperative Complications / Q000453:epidemiology; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone